Workflow
Jalon(688357)
icon
Search documents
建龙微纳:股东深云龙减持1060000股
Zheng Quan Ri Bao· 2026-02-27 14:20
证券日报网讯 2月27日,建龙微纳发布公告称,2026年2月27日,上海深云龙企业发展有限公司通过大 宗交易减持公司1060000股,占总股本1.06%,持股降至5340800股,占比由6.40%降至5.34%。 (文章来源:证券日报) ...
建龙微纳(688357) - 关于持股5%以上股东权益变动触及1%刻度的提示性公告
2026-02-27 10:32
证券代码:688357 证券简称:建龙微纳 公告编号:2026-011 转债代码:118032 转债简称:建龙转债 洛阳建龙微纳新材料股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的 提示性公告 | | ☐控股股东/实际控制人及其一致行动人 | | --- | --- | | | ☑其他 5%以上大股东及其一致行动人 | | 投资者及其一致行动人的身份 | ☐合并口径第一大股东及其一致行动人(仅适用 | | | 于无控股股东、实际控制人) | | | ☐其他______________(请注明) | 上海深云龙企业发展有限公司保证向本公司提供的信息真实、准确、 完整,没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息 一致。 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 重要内容提示: 权益变动方向 比例增加☐ 比例减少☑ 权益变动前合计比例 6.40% 权益变动后合计比例 5.34% 本次变动是否违反已作出的承 诺、意向、计划 是☐ 否☑ 是否触发强制要约收购义务 是☐ 否☑ 3.一致行动人信息 上述股东无一致行动人。 二、 权益变动 ...
建龙微纳(688357.SH)2025年度归母净利润9852.38万元,同比增长31.79%
智通财经网· 2026-02-26 13:24
2025年,公司紧密围绕"强基固本,坚持创新"的经营方针,在巩固传统分子筛吸附剂业务的同时积极开 发新领域新产品,稳步推进向新材料及技术服务领域的产业延伸。 智通财经APP讯,建龙微纳(688357.SH)披露2025年度业绩快报,2025年度公司实现营业总收入8.41亿 元,同比增长7.97%;归属于母公司所有者的净利润9852.38万元,同比增长31.79%。 ...
建龙微纳2025年度归母净利润9852.38万元,同比增长31.79%
Zhi Tong Cai Jing· 2026-02-26 13:23
2025年,公司紧密围绕"强基固本,坚持创新"的经营方针,在巩固传统分子筛吸附剂业务的同时积极开 发新领域新产品,稳步推进向新材料及技术服务领域的产业延伸。 建龙微纳(688357.SH)披露2025年度业绩快报,2025年度公司实现营业总收入8.41亿元,同比增长7.97%; 归属于母公司所有者的净利润9852.38万元,同比增长31.79%。 ...
优化产品结构与降本并行 建龙微纳2025年归母净利润同比增长31.79%
Zheng Quan Ri Bao Wang· 2026-02-26 12:27
数据显示,2025年建龙微纳实现营业收入8.41亿元,同比增长7.97%;实现归母净利润9852.38万元,同 比增长31.79%;实现扣非净利润9465.16万元,同比增长55.75%;实现毛利率31.92%,较上年同期提高 3.57个百分点。 对于营收和净利润同比增长的原因,建龙微纳表示,主要系公司深化市场拓展,营业收入同比有所增 长;同时,公司通过优化产品结构,持续实施降本增效举措,毛利率同比提升3.57个百分点,以上因素 共同使得公司业绩实现同比较大幅度的增长。 建龙微纳相关负责人对《证券日报》记者表示,报告期内,公司持续优化产品结构,现有百余款产品中 均布局高毛利品类,各应用场景下高毛利产品销量同比显著提升,成为拉动整体毛利率上行的重要动 力。 2月26日晚间,洛阳建龙微纳新材料股份有限公司(以下简称"建龙微纳")发布的业绩快报显示,2025 年公司整体经营稳步向好,盈利能力和经营质量持续提升。 公开资料显示,建龙微纳主要从事工业气体分离、医用氧气、能源化工、石油化工、环境治理等领域的 相关分子筛吸附剂和催化剂的研发、生产、销售及技术服务。该公司产品的性能指标均具有与国际大型 分子筛企业竞争的能力, ...
建龙微纳(688357) - 2025 Q4 - 年度业绩
2026-02-26 09:45
| 证券代码:688357 | 证券简称:建龙微纳 | 公告编号:2026-010 | | --- | --- | --- | | 转债代码:118032 | 转债简称:建龙转债 | | 洛阳建龙微纳新材料股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载2025年度主要财务数据为初步核算数据,未经会计师事务所审计, 具体数据以洛阳建龙微纳新材料股份有限公司(以下简称"公司")2025年年度报 告为准,提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位:人民币万元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度(%) | | --- | --- | --- | --- | | 营业总收入 | 84,084.89 | 77,874.97 | 7.97 | | 营业利润 | 10,963.48 | 8,972.74 | 22.19 | | 利润总额 | 10,806.37 | 8,782.79 | 23.04 | | 归属于母公司所有者 的净利润 | ...
建龙微纳:2025年度净利润9852.38万元,同比增长31.79%
Ge Long Hui· 2026-02-26 09:41
主营业务方面,公司在气体分离、医用制氧、吸附干燥等分子筛吸附剂领域继续保持竞争优势,持续加 强市场开拓,销售收入实现增长,成本控制成效显现,带动毛利率稳步回升,为后续技术研发与产业拓 展提供了支撑。海外业务方面,报告期内外销收入21,691.57万元,同比增长9.00%,占营收比例 25.80%。海外基地的稳定运营增强了公司应对国际贸易环境变化的能力,也为进一步拓展海外市场奠 定了基础。 2026年,公司继续坚持国内国际双轮驱动发展,继续聚焦石油化工、能源化工、可再生资源、可再生能 源四大领域,稳步推动业务模式从新材料制造向综合技术服务转型,全面赋能公司高质量发展。 格隆汇2月26日丨建龙微纳(688357.SH)公布2025年度业绩快报,2025年,公司紧密围绕"强基固本,坚 持创新"的经营方针,在巩固传统分子筛吸附剂业务的同时积极开发新领域新产品,稳步推进向新材料 及技术服务领域的产业延伸。全年实现营业收入8.41亿元,同比增长7.97%,实现归母净利润9,852.38万 元,同比增长31.79%,实现扣非净利润9,465.16万元,同比增长55.75%,实现毛利率31.92%,较上年同 期提高3.57个 ...
建龙微纳:2025年净利润9852.38万元,同比增长31.79%
Xin Lang Cai Jing· 2026-02-26 09:33
建龙微纳发布业绩快报,2025年度公司实现营业总收入8.41亿元,同比增长7.97%;净利润9852.38万 元,同比增长31.79%。公司紧密围绕"强基固本,坚持创新"的经营方针,在巩固传统分子筛吸附剂业务 的同时积极开发新领域新产品,稳步推进向新材料及技术服务领域的产业延伸。 ...
建龙微纳战略转型加速,机构调研关注SAF催化剂与CCUS进展
Jing Ji Guan Cha Wang· 2026-02-13 04:59
Core Viewpoint - Company is transforming into a comprehensive technology service provider through the acquisition of a 40% stake in Hanxing Energy, while making progress in sustainable aviation fuel catalysts and carbon dioxide capture [1][2][4]. Recent Events - On December 23, 2025, the company announced its wholly-owned subsidiary's plan to acquire 40% of Hanxing Energy for 200 million yuan, aiming to integrate molecular sieve materials and process engineering capabilities [2]. - On February 9, 2026, during an investor survey, the company emphasized that this move is part of a long-term strategic layout to enhance its "materials + processes + equipment" full-chain solution capabilities [2]. Company Structure and Governance - On February 6, 2026, the company held its 17th meeting of the fourth board of directors, reviewing documents related to governance and funding arrangements, including a proposal to provide guarantees for its wholly-owned subsidiary [3]. Institutional Research - On January 23, 2026, the company was surveyed by multiple institutions, revealing advancements in sustainable aviation fuel catalysts and carbon capture utilization and storage (CCUS) [4]. - The company stated that the SAF market has broad prospects, with its specialized molecular sieve catalysts having completed downstream side-line testing, and CCUS being a key new direction under the "dual carbon" goals [4]. Financial Movements - As of February 2, 2026, the company's financing balance was 134 million yuan, accounting for 3.95% of its circulating market value, at a near one-year high; on the same day, net financing sold out was 627,600 yuan, with a stock price drop of 2.40% [5]. - The company's Q3 2025 report showed revenue of 590 million yuan for the first three quarters (up 4.34% year-on-year) and a net profit attributable to shareholders of 72.73 million yuan (up 20.15% year-on-year) [5]. - Recent shareholder changes include a reduction of 892,100 shares announced on January 5, 2026, and three institutions have given buy ratings in the last 90 days [5].
出海企业的财富密码丨小小分子筛 出海闯天下
He Nan Ri Bao· 2026-02-08 23:28
Core Viewpoint - The article highlights the significant growth and international expansion of Jianlong Micro-Nano, a leading Chinese molecular sieve manufacturer, particularly through its new production base in Thailand, which is set to enhance its global market presence and operational capabilities [4][6]. Group 1: Company Performance - Jianlong Micro-Nano reported a sales revenue increase of 82.7% and a net profit increase of 129.6% year-on-year for the first three quarters of the previous year, indicating strong financial health and confidence in overseas expansion [4]. - The company has established itself as the leading producer of adsorption molecular sieves in China and ranks third globally, marking a significant transformation from a local manufacturer to an internationally recognized brand [4]. Group 2: Production and Technology - The production facility in Thailand utilizes advanced automation and high-tech processes, including intelligent mixing, high-temperature roasting, and micron-level detection, to produce molecular sieves that are crucial for both medical and industrial applications [4][5]. - The Thai facility is expected to achieve an annual production capacity of 24,000 tons by mid-2025, reflecting the company's commitment to local manufacturing and supply chain efficiency [4]. Group 3: Strategic Expansion - The decision to establish operations in Thailand is driven by the rapid development of ASEAN countries in sectors such as refining, natural gas, and clean energy, with Thailand being a mature market and a key player in the RCEP and Belt and Road initiatives [6]. - The company has adopted a localization strategy, employing over 90% local staff and engaging in community support activities, which has helped it to establish a strong foothold in the Southeast Asian market [7]. Group 4: Future Outlook - Jianlong Micro-Nano is focusing on sustainable aviation fuels and new energy storage as emerging fields for future growth, aiming to replace imports and build a globally recognized brand in the molecular sieve industry [8]. - The company is also in the process of establishing an office in India to expand its reach into the Middle East and other markets, further solidifying its global strategy [8].